Standard laboratory markers were available for the total amount of 155 patients and were analyzed in the central laboratory at University Hospital RWTH Aachen using a Sysmex XN9000 (Sysmex GmbH, Norderstedt, Germany) and a Cobas 8000 c701 (Hoffmann-La Roche AG, Basel, Switzerland) platform according to the manufacturer’s instructions. For a small subset of patients (n = 17) serum samples upon ICU admission were available for serum concentration determination of markers beyond the clinical routine including adiponectin. Peripheral or central venous blood was obtained at ICU admission prior to any therapeutic intervention. Blood samples were centrifuged (2,000 x g for 10 minutes) and serum samples were stored at −80°C until use. Serum adiponectin levels were analyzed in a blinded fashion by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s instructions (No. EZHADP-61K, MERCK Millipore, Schwalbach, Germany).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.